Stemline Therapeutics, Inc. (STML): Price and Financial Metrics


Stemline Therapeutics, Inc. (STML): $11.83

-0.17 (-1.42%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add STML to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

STML Stock Price Chart Interactive Chart >

Price chart for STML

STML Price/Volume Stats

Current price $11.83 52-week high $18.22
Prev. close $12.00 52-week low $3.21
Day low $11.82 Volume 17,354,300
Day high $12.10 Avg. volume 1,524,566
50-day MA $8.63 Dividend yield N/A
200-day MA $8.77 Market Cap 621.21M

Stemline Therapeutics, Inc. (STML) Company Bio


Stemline Therapeutics is a clinical stage biopharmaceutical company developing novel therapeutics that target cancer stem cells (CSCs) and tumor bulk. The company was founded in 2003 and is based in New York, New York.


STML Latest News Stream


Event/Time News Detail
Loading, please wait...

STML Latest Social Stream


Loading social stream, please wait...

View Full STML Social Stream

Latest STML News From Around the Web

Below are the latest news stories about Stemline Therapeutics Inc that investors may wish to consider to help them evaluate STML as an investment opportunity.

Stemline Therapeutics acquired by Menarini Group

Menarini Group completed acquisition of Stemline Therapeutics (STML) for aggregate cash consideration up to $677M. Details here.Through the acquisition, Menarini's U.S. presence would be established and it will enable global expansion by leveraging its commercial infrastructure in Europe and other geographies.Acquisition to bolster Menarini’s oncology portfolio with the addition of both commercial...

Seeking Alpha | June 10, 2020

Lifshitz Law Firm, P.C. Announces Investigation of Franklin Financial Network, Inc., Mobile Mini, Inc., Portola Pharmaceuticals, Inc., resTORbio, Inc., Stemline Therapeutics, Inc., Taubman Centers, Inc. and Willis Towers Watson Public Limited Company and Wright Medical Group N.V.

Franklin Financial Network, Inc. (FSB)

Yahoo | May 28, 2020

SHAREHOLDER ALERT: WeissLaw LLP Reminds STML, PTLA, and QES Shareholders About Its Ongoing Investigations

NEW YORK, May 21, 2020 -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice.

Yahoo | May 21, 2020

NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: QUINTANA ENERGY SERVICES, INC. (NYSE - QES), STEMLINE THERAPEUTICS, INC. (NASDAQ - STML) AND resTORbio, Inc. (NasdaqGS - TORC)

BALA CYNWYD, PA / ACCESSWIRE / May 19, 2020 / Brodsky & Smith, LLC reminds investors of investigations it is conducting regarding the following companies for possible breaches of fiduciary duty and other ...

Yahoo | May 19, 2020

STEMLINE ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of STML and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Stemline Therapeutics, Inc. (STML) breached their fiduciary duties or violated the federal securities laws in connection with the company’s proposed merger with Menarini Group. On May 4, 2020, Stemline announced that it had signed an agreement to be acquired by Menarini for up to $677 million through a tender offer effected by certain Menarini affiliates. According to the merger agreement, Stemline’s stockholders will receive $11.50 in cash and the chance to receive an additional $1.00 per share upon the first sale of ELZONRIS in any EU5 country after European Commission approval.

Yahoo | May 19, 2020

Read More 'STML' Stories Here

STML Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -13.65%
5-year 40.00%
YTD N/A
2021 N/A
2020 0.00%
2019 11.89%
2018 -39.10%
2017 45.79%

Continue Researching STML

Here are a few links from around the web to help you further your research on Stemline Therapeutics Inc's stock as an investment opportunity:

Stemline Therapeutics Inc (STML) Stock Price | Nasdaq
Stemline Therapeutics Inc (STML) Stock Quote, History and News - Yahoo Finance
Stemline Therapeutics Inc (STML) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6442 seconds.